BMI
Overvalued by 8.7% based on the discounted cash flow analysis.
Market cap | $7.17 Billion |
---|---|
Enterprise Value | $7.11 Billion |
Dividend Yield | $1.36 (0.558338122998604%) |
Earnings per Share | $4.26 |
Beta | 0.85 |
Outstanding Shares | 29,378,491 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 53.32 |
---|---|
PEG | 167.61 |
Price to Sales | 8.4 |
Price to Book Ratio | 11.6 |
Enterprise Value to Revenue | 8.34 |
Enterprise Value to EBIT | 40.75 |
Enterprise Value to Net Income | 52 |
Total Debt to Enterprise | 0.01 |
Debt to Equity | 0.1 |
No data
No data